Nov 14, 2024 04:05PM
Oct 15, 2024 08:00AM
Sep 17, 2024 07:01AM
Sep 17, 2024 07:00AM
Aug 14, 2024 07:01AM
Aug 14, 2024 07:00AM
Aug 6, 2024 07:00AM Omega Therapeutics Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress
Jul 17, 2024 08:00AM
Jun 24, 2024 07:01AM
Jun 24, 2024 07:00AM
May 29, 2024 07:02AM
May 29, 2024 07:00AM
May 8, 2024 07:01AM
May 8, 2024 07:00AM Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic Controllers
May 6, 2024 07:00AM
Apr 23, 2024 07:00AM
Apr 9, 2024 07:20AM
Apr 9, 2024 07:00AM
Mar 28, 2024 09:15AM
Mar 6, 2024 07:00AM
Nov 13, 2023 07:00AM Omega Therapeutics Showcases Bidirectional and Multiplexed Epigenomic Control of Gene Expression in Preclinical Models of Liver Inflammation and Fibrosis
Nov 9, 2023 07:00AM
Oct 31, 2023 07:00AM
Oct 19, 2023 10:30AM
Oct 16, 2023 07:01AM
Oct 16, 2023 07:00AM
Oct 11, 2023 04:00PM
Oct 4, 2023 04:00PM Omega Therapeutics to Present New Preclinical Data on OTX-2101 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Sep 26, 2023 07:01AM
Sep 26, 2023 07:00AM
Sep 25, 2023 04:00PM
Aug 29, 2023 07:01AM
Aug 29, 2023 07:00AM
Aug 3, 2023 04:00PM
Jul 12, 2023 07:04AM Omega Therapeutics (OMGA) Appoints Chris Schade to its Board
Jul 12, 2023 07:00AM
May 31, 2023 07:00AM
May 4, 2023 07:00AM
Apr 27, 2023 07:00AM
Apr 27, 2023 07:00AM
Mar 30, 2023 07:02AM
Mar 30, 2023 07:00AM Omega Therapeutics Announces Clinical Supply Agreement to Evaluate the Combination of OTX-2002 and Atezolizumab in Hepatocellular Carcinoma
Mar 30, 2023 07:00AM
Mar 1, 2023 07:00AM
Mar 1, 2023 07:00AM
Jan 17, 2023 07:00AM
Jan 17, 2023 07:00AM
Nov 15, 2022 07:00AM
Nov 8, 2022 07:00AM Omega Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
Nov 2, 2022 07:01AM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All